Am Heart J

1. CROWLEY R, Azzopardi S, Curtin A, Rendell G, et al
   Yoga vs Regular Exercise for Atrial Fibrillation: Design of the Yoga-AF Randomized Controlled Trial.
   Am Heart J. 2025 Sep 22:S0002-8703(25)00332-1. doi: 10.1016/j.ahj.2025.
   

   >> Share

   
   

   
   Am J Cardiol

2. BUTT JH, Bundgaard JS, Schou M, Yafasova A, et al
   Implantable Cardioverter-Defibrillator And Frailty In Non-ischemic Heart Failure With Reduced Ejection Fraction: Extended Follow-Up Of The DANISH Trial.
   Am J Cardiol. 2025 Sep 23:S0002-9149(25)00577.
   

   >> Share

   
   

   
   Cardiovasc Res

3. ISHIKAWA T, Kimoto H, Seki A, Shirai M, et al
   Phenotypic spectrum of cardiac conduction disturbance and cardiomyopathy linked to titin canonical splice-site variants.
   Cardiovasc Res. 2025;121:1712-1721.
   

   >> Share

   
   

   
   Circ Arrhythm Electrophysiol

4. BRANT LCC, Ribeiro AH, Eromosele OB, Pinto-Filho MM, et al
   Prediction of Atrial Fibrillation From the ECG in the Community Using Deep Learning: A Multinational Study.
   Circ Arrhythm Electrophysiol. 2025 Sep 30:e013734.
   

   >> Share

   
   
5. ZHOU Z, Zhang H, Xiong H, Deng KQ, et al
   Inhibition of Satellite Glial Cell Activation in Stellate Ganglia Prevents Ventricular Arrhythmogenesis and Remodeling After Myocardial Infarction.
   Circ Arrhythm Electrophysiol. 2025 Sep 30:e013866.
   

   >> Share

   
   
6. ZHENG C, Hu WM, Lin WQ, Lin YF, et al
   Rapid Electrocardiographic Protocol for Identifying Ventricular Arrhythmias From Specific Sites of the Right Coronary Cusp.
   Circ Arrhythm Electrophysiol. 2025 Sep 30:e012936.
   

   >> Share

   
   
7. ELLENBOGEN KA, Khoynezhad A, La Meir M, de Asmundis C, et al
   Dual Epicardial and Endocardial Procedure (DEEP) for Persistent or Longstanding Persistent Atrial Fibrillation.
   Circ Arrhythm Electrophysiol. 2025 Sep 30:e013692.
   

   >> Share

   
   
8. CERON C, Dalsania R, Farkouh F, Dong J, et al
   Mexiletine as Adjunctive Therapy in Atrial Fibrillation Following Dofetilide Treatment Failure.
   Circ Arrhythm Electrophysiol. 2025 Sep 25:e014055.
   

   >> Share

   
   

   
   Circulation

9. MORI Y, Sawano M, Kohsaka S, Tsugawa Y, et al
   Screening-Detected Atrial Fibrillation and Cardiovascular Outcomes in Working-Age Adults.
   Circulation. 2025 Sep 25. doi: 10.1161/CIRCULATIONAHA.125.074433.
   

   >> Share

   
   
10. REDEL-TRAUB G, Marx SO, Marks AR
    Targeting Calcium Regulation for Heart Failure and Arrhythmia Therapeutics: A Critical Review.
    Circulation. 2025;152:957-970.
    

    >> Share

    
    

    
    Eur Heart J

11. REINSTADLER SJ, Schreinlechner M, Bauer A
    Digital screening for atrial fibrillation to prevent stroke: the Austrian Digital Heart Program.
    Eur Heart J. 2025 Oct 3:ehaf714. doi: 10.1093.
    

    >> Share

    
    
12. NAKASHIMA K, Yamaguchi T, Takahashi Y, Otsubo T, et al
    Sex differences in atrial fibrillation-related atrial remodelling assessed by electroanatomic mapping and biopsy.
    Eur Heart J. 2025 Sep 25:ehaf768. doi: 10.1093.
    

    >> Share

    
    
13. MATHIJSSEN H, Bawaskar PH, Shenoy C
    Cardiovascular magnetic resonance phenotyping: the new standard for primary prevention implantable cardioverter-defibrillator decision-making in cardiac sarcoidosis.
    Eur Heart J. 2025 Sep 25:ehaf759. doi: 10.1093.
    

    >> Share

    
    
14. POYHONEN P, Kandolin R, Kupari M
    Cardiovascular magnetic resonance in the assessment of the risk of fatal or life-threatening ventricular arrhythmias in suspected vs diagnosed cardiac sarcoidosis.
    Eur Heart J. 2025 Sep 25:ehaf758. doi: 10.1093.
    

    >> Share

    
    

    
    Heart

15. YANG S, De Kruijf N, Zhu F, van Oortmerssen JAE, et al
    Trends in burden of atrial fibrillation over three decades: a population-based study.
    Heart. 2025 Sep 27:heartjnl-2025-326510. doi: 10.1136/heartjnl-2025-326510.
    

    >> Share

    
    

    
    Int J Cardiol

16. MATSUOKA Y, Sakamoto D, Sunaga A, Okada K, et al
    Clinical impact of kidney function in patients with atrial fibrillation receiving oral anticoagulants.
    Int J Cardiol. 2025;443:133942.
    

    >> Share

    
    

    
    J Cardiovasc Electrophysiol

17. EMBREY PH, Mohanty S, Torlapati PG, La Fazia VM, et al
    Long-Term Outcome of Radiofrequency Versus Pulsed-Field Ablation in Atrial Fibrillation Patients Aged More Than 60 Years Undergoing Their First Catheter Ablation.
    J Cardiovasc Electrophysiol. 2025 Sep 25. doi: 10.1111/jce.70101.
    

    >> Share

    
    
18. CELENTANO E, Cristiano E, Bertella E, Parrinello M, et al
    Functional Gaps and Atrial Fibrosis as Predictors of Early Arrhythmia Recurrence After Robotic-Enhanced Hybrid Ablation for Persistent Atrial Fibrillation.
    J Cardiovasc Electrophysiol. 2025 Sep 29. doi: 10.1111/jce.70117.
    

    >> Share

    
    
19. HSIA BC, Zhang P, Junarta J, Garber L, et al
    Vein of Marshall Ethanol Ablation as a Strategy for Recurrent Persistent Atrial Fibrillation.
    J Cardiovasc Electrophysiol. 2025 Sep 29. doi: 10.1111/jce.70114.
    

    >> Share

    
    
20. SILVERSTEIN JR, Gupta M, Jackson T, Duan C, et al
    Management of Atrial Flutter (AFL) Using Intrinsic Antitachycardia Pacing (iATP) Protocol.
    J Cardiovasc Electrophysiol. 2025 Oct 2. doi: 10.1111/jce.70115.
    

    >> Share

    
    
21. TACHIBANA S, Inaba O, Inamura Y, Takagi T, et al
    Role of Interatrial Septal Adipose Tissue Volume and Attenuation in Predicting Atrial Tachyarrhythmias Recurrence Following Catheter Ablation.
    J Cardiovasc Electrophysiol. 2025 Oct 2. doi: 10.1111/jce.70124.
    

    >> Share

    
    
22. CREA P, Giustetto C, Micari A, Bruno L, et al
    A Novel Variant in SLC4A3 Gene Mutation Associated With Familial Short QT Syndrome and Sudden Death.
    J Cardiovasc Electrophysiol. 2025 Oct 2. doi: 10.1111/jce.70126.
    

    >> Share

    
    
23. MARIANI MV, Recchioni T, Pierucci N, Trivigno S, et al
    Prognostic Impact of Spontaneous Conversion to Sinus Rhythm in Patients With Symptomatic Paroxysmal Atrial Fibrillation: A Propensity-Matched Follow-Up Study.
    J Cardiovasc Electrophysiol. 2025 Oct 2. doi: 10.1111/jce.70128.
    

    >> Share

    
    

    
    J Cardiovasc Pharmacol

24. TISDALE JE, Jaynes HA, Overholser BR, Sowinski KM, et al
    Dihydrotestosterone Pretreatment Diminishes the Severity of Drug-Induced Torsades de Pointes.
    J Cardiovasc Pharmacol. 2025;86:343-349.
    

    >> Share

    
    

    
    J Interv Card Electrophysiol

25. KAN KY, Van Wyk A, Paterson T, Ninan N, et al
    Beyond the type 1 pattern: comprehensive risk stratification in Brugada syndrome.
    J Interv Card Electrophysiol. 2025;68:1771-1790.
    

    >> Share

    
    
26. KIVRAK A, Ates AH, Dogan M, Coteli C, et al
    Pulmonary artery perforation after percutaneous left atrial appendage closure: two case reports and review of literature.
    J Interv Card Electrophysiol. 2025;68:1761-1769.
    

    >> Share

    
    
27. YOGARAJAH J, Hutter J, Kahle P, Beaujean P, et al
    Acute outcomes of cryoballoon vs. circular vs. pentaspline pulsed-field ablation catheters in combined pulmonary vein isolation and roof line ablation.
    J Interv Card Electrophysiol. 2025;68:1637-1646.
    

    >> Share

    
    
28. BADERTSCHER P, Arnet R, Isenegger C, Subin B, et al
    Long-term follow up of single-chamber atrial pacing-system upgrade and Wenckebach block point behavior: potential implications for leadless AAI pacing?
    J Interv Card Electrophysiol. 2025;68:1605-1612.
    

    >> Share

    
    
29. CHOPRA M, Hsieh JC, Mueller W, Braunstein ED, et al
    Incidence of pacing-induced cardiomyopathy: left bundle branch area pacing versus leadless pacing.
    J Interv Card Electrophysiol. 2025;68:1585-1592.
    

    >> Share

    
    
30. ONDER SE, Guler TE, Bozyel S, Cagdas M, et al
    Integration of automated peak frequency annotation with voltage mapping for identifying ventricular tachycardia ablation sites.
    J Interv Card Electrophysiol. 2025;68:1573-1583.
    

    >> Share

    
    
31. GOTO K, Miyazaki S, Nakamura K, Nitta J, et al
    A randomized controlled trial of two pulsed field ablation systems for paroxysmal atrial fibrillation: the DUAL-PULSE trial rationale and design.
    J Interv Card Electrophysiol. 2025 Oct 3. doi: 10.1007/s10840-025-02137.
    

    >> Share

    
    
32. RORDORF R, Bianchi S, Dello Russo A, Solimene F, et al
    Conventional pulsed-field ablation versus pulsed-field ablation with non-integrated three-dimensional mapping for paroxysmal and persistent atrial fibrillation ablation.
    J Interv Card Electrophysiol. 2025 Oct 3. doi: 10.1007/s10840-025-02129.
    

    >> Share

    
    
33. HAMMAD A, Ahmad A, Khalid N, Munshi H, et al
    Efficacy and safety of left atrial appendage occlusion for atrial fibrillation in patients with a history of prior intracranial hemorrhage: a systematic review and meta-analysis of observational studies.
    J Interv Card Electrophysiol. 2025 Sep 30. doi: 10.1007/s10840-025-02136.
    

    >> Share

    
    

    
    PLoS One

34. JUNG WJ, Roh YI, Kim S, Im H, et al
    Right ventricular pressure-volume relations and effects of selective vena cava occlusion during cardiopulmonary resuscitation.
    PLoS One. 2025;20:e0333122.
    

    >> Share

    
    

    
    Resuscitation

35. GAMBERINI L, Carinci V, Pallavicini P, Rovera M, et al
    Prehospital management of supraventricular tachycardia: a multicentre study of current practices with a subgroup propensity score-based comparison of adenosine and electrical cardioversion in unstable patients.
    Resuscitation. 2025;215:110707.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share